Followers | 715 |
Posts | 21821 |
Boards Moderated | 4 |
Alias Born | 04/30/2007 |
Wednesday, March 01, 2017 11:18:52 AM
Marketwired MarketwiredFebruary 27, 2017
NEW YORK, NY--(Marketwired - Feb 27, 2017) - Rising India Inc. ( OTC : RSII ) has received several requests from shareholders for a recap to the Company's Shareholder Conference call which featured detailed information about the incoming merger company, Rising Biosciences, Inc.
Rising BioSciences, Inc. will be a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry. Aside from cancer treatment and pain management, some of the uses for medical marijuana include treatment of conditions such as seizure disorders, multiple sclerosis, Parkinson's disease, rheumatoid arthritis, glaucoma and Crohn's disease.
Rising Biosciences is comprised of a team of chemists, physicians, pharmacists and medical marijuana industry veterans for the development of products in a clinical lab environment. Operations will focus on creating product that can be metabolized by the body more efficiently, and with delivery methods more acceptable than smoking, tinctures and oils available on the market today.
Procedures will include consistency in terms of quality and true dosage measures of CBD and/or THC delivery through each product the company develops and manufactures.
To date, the industry suffers from a lack of overall quality control of product, including accurate dosage. Rising Biosciences intends to be an industry standout by using policies and procedures set forth by the compounding pharmaceutical industry while monitoring safety and quality throughout.
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindia
Post by StockRocket
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM